Sign in
Groups
Researchers
Funding
Results
Linfomas
GLUN
Hadassah Medical Center
Jerusalén, Israel
You are in
Collaborations
Hadassah Medical Center
Publications in collaboration with researchers from Hadassah Medical Center (1)
2018
A phase ii multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy
Haematologica, Vol. 103, Núm. 8, pp. 1351-1358
Contact
Legal notice
Help
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
ca
eu
gl
fr
de